Berends, S. E., van Steeg, T. J., Ahsman, M. J., Singh, S., Brandse, J. F., D’Haens, G. R. A. M., & Mathôt, R. A. A. (2019). Tumor necrosis factor-mediated disposition of infliximab in ulcerative colitis patients. J Pharmacokinet Pharmacodyn.

Berends, Sophie E., Tamara J. van Steeg, Maurice J. Ahsman, Sharat Singh, Johannan F. Brandse, Geert R. A. M. D’Haens, et Ron A. A. Mathôt. "Tumor Necrosis Factor-mediated Disposition of Infliximab in Ulcerative Colitis Patients." J Pharmacokinet Pharmacodyn 2019.

Berends, Sophie E., et al. "Tumor Necrosis Factor-mediated Disposition of Infliximab in Ulcerative Colitis Patients." J Pharmacokinet Pharmacodyn 2019.